Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: The top 10 most-read blog posts in 2024
Happy New Year! With so much information available online, thank you for choosing to read the content on Signals. Whether you are a subscriber and a loyal reader, or you follow a particular blogger or category, your readership is appreciated! As of this writing, here are the blogs that attracted the most readers in 2024, […]
CGTs and the Gartner Hype Cycle
Are you familiar with the Gartner Hype Cycle? It’s a way of separating reality from hype when it comes to emerging technologies – like cell and gene therapies (CGTs). The hype cycle employs a graph to present the maturity of new technologies as they pass through five phases. Learn more here. The Gartner Hype Cycle […]
Right Turn: Some takeaways from Advanced Therapies Week 2025
In a new location, with highways replacing waterways, it’s comforting to have an agenda with some consistent touchpoints for familiarity, and Advanced Therapies Week 2025 (ATW25), January 20-23 in Dallas, Texas, began with two of my favourites: the Super plenary, moderated by Anthony Davies, Dark Horse Consulting Group, and the Opening plenary, featuring Susan Nichols, […]